Efungumab
Efungumab ( trade name Mycograb ) was a drug developed by NeuTec Pharma ( a subsidiary of Novartis ) , intended to treat candidemia ( a bloodstream infection caused by pathogenic yeast ) in combination with amphotericin B . 
<triplet> amphotericin B <subj> drug <obj> instance of